Summary
Machine-generated summaryThe healthcare buyer Zespól Opieki Zdrowotnej w Oswiecimiu awarded a contract for the successive supply of chemotherapy medicines and medicines for drug programmes for 2026. The purchase covers 16 packages of cancer and related medicines, including methotrexate, bevacizumab, abiraterone, sorafenib, imatinib, osimertinib, atezolizumab, enzalutamide, ofatumumab, sunitinib, panitumumab, cabazitaxel, ozanimod, ipilimumab, cemiplimab and alectinib. The contract was awarded on 2025-12-12 to SALUS INTERNATIONAL SP. Z O.O., FARMACOL-LOGISTYKA SP. Z O.O., OPTIFARMA SP. Z O.O. SP.K., ASTRAZENECA KFT., ROCHE POLSKA SP. Z O.O., ASTELLAS PHARMA SP. Z O.O., AMGEN SP. Z O.O. and URTICA SP. Z O.O. for EUR 1,307,114.59.
Description
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 8 hours ago
More from this buyer
Full buyer profile8 open tenders right now
- Successive delivery of reagents, control materials and consumables together with rental of a set for automatic analysis of physicochemical parameters and urine sediment 2 days left
- Pharmaceutical products - Supply of medicines for 2027 Part III 20 days left
- Pharmaceutical products - SUPPLY OF MEDICINES FOR 2027 PART II 20 days left
Recent awards
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €11,085,809
- Buyer track record on Aperlena
- 127 notices tracked · 70 awarded
- €14,347,550 in awarded contracts
Never miss a tender like this
891 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alert